Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLKB1 | P03952 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | IRAK4 | Q9NWZ3 | 11/20 | 0.34 |
| ▸ | ACACB | O00763 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL38654637 | 0.98 | KLKB1 (0.34) | KLKB1CYP11B1CYP11B2LMNAPOLB | |
| SCHEMBL8932291 | 0.94 | CYP11B1 (0.33) | KLKB1CYP11B1CYP11B2LMNAPOLB | |
| SCHEMBL9266924 | 0.89 | LMNA (0.35) | LMNAPOLBIRAK4ACACBGAA | |
| SCHEMBL3251664 | 0.85 | GAA (0.34) | LMNAPOLBGAAALDH1A1SMN1; SMN2 | |
| SCHEMBL20141 | 0.84 | IRAK4 (0.35) | KLKB1CYP11B1CYP11B2LMNAPOLB | |
| SCHEMBL14010542 | 0.84 | LMNA (0.35) | KLKB1CYP11B1CYP11B2LMNAPOLB | |
| SCHEMBL11893139 | 0.84 | RAB9A (0.34) | LMNAPOLBGAAALDH1A1SMN1; SMN2 | |
| SCHEMBL21326127 | 0.83 | KLKB1 (0.34) | KLKB1CYP11B1CYP11B2LMNAPOLB | |
| SCHEMBL22234827 | 0.83 | ALDH1A1 (0.40) | KLKB1CYP11B1CYP11B2LMNAPOLB | |
| SCHEMBL22843773 | 0.83 | IRAK4 (0.40) | KLKB1LMNAPOLBIRAK4ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 497 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12509417-B2 | Enantioselective process | SYNGENTA CROP PROTECTION AG (CH) | 2025-12-30 | — | — | US | claimed |
| US-12491503-B2 | Hydrogenation process of oxime derivatives | SYNGENTA CROP PROTECTION AG (CH) | 2025-12-09 | — | — | US | claimed |
| WO-2025074339-A1 | A PROCESS FOR PREPARATION OF CARBOXAMIDE COMPOUNDS AND INTERMEDIATES THEREOF | UPL LIMITED (IN) | 2025-04-10 | — | — | WO | claimed |
| CN-119056375-B | Preparation method of fluxapyroxad | 天津凯莱英医药科技发展有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119285548-A | Fluoconazole fungus Process for the preparation of amides | 湖南化工研究院有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-113195460-B | Enantioselective process | 先正达农作物保护股份公司 | 2024-07-19 | — | — | CN | claimed |
| CN-118324696-A | Key raw material for detecting bixafen as well as preparation method and application thereof | 福建省农业科学院农业质量标准与检测技术研究所 | 2024-07-12 | — | — | CN | claimed |
| EP-3877394-B1 | HYDROGENATION PROCESS OF OXIME DERIVATIVES | SYNGENTA CROP PROTECTION AG (CH) | 2024-06-26 | — | — | EP | claimed |
| CN-116162063-B | Pyrazole formylhydroxylamine compound containing bisamide bond, and preparation method and application thereof | 浙江工业大学 | 2024-05-28 | — | — | CN | claimed |
| CN-116239533-B | Difluoromethyl pyrazole carboxamide compounds containing benzoate (amide), preparation method and application thereof | 浙江工业大学 | 2024-05-24 | — | — | CN | claimed |
| CN-114957123-B | 3- (difluoromethyl) -pyrazole-4-carboxylic ester derivative and preparation method and application thereof | 浙江工业大学 | 2023-11-28 | — | — | CN | claimed |
| EP-3877372-B1 | ENANTIOSELECTIVE REDUCTION OF OXIME-DERIVATIVES INVOLVING IRIDIUM BASED CATALYSTS | SYNGENTA CROP PROTECTION AG (CH) | 2023-08-02 | — | — | EP | claimed |
| CN-116239533-A | Difluoromethyl pyrazole carboxamide compounds containing benzoate (amide), preparation method and application thereof | 浙江工业大学 | 2023-06-09 | — | — | CN | claimed |
| CN-116178264-A | Synthesis method of bixafen | 西安近代化学研究所 | 2023-05-30 | — | — | CN | claimed |
| CN-116162063-A | Pyrazole formylhydroxylamine compound containing bisamide bond, and preparation method and application thereof | 浙江工业大学 | 2023-05-26 | — | — | CN | claimed |
| CN-114957123-A | 3- (difluoromethyl) -pyrazole-4-carboxylic ester derivative and preparation method and application thereof | 浙江工业大学 | 2022-08-30 | — | — | CN | claimed |
| US-20220106263-A1 | ENANTIOSELECTIVE PROCESS | SYNGENTA CROP PROTECTION AG (CH) | 2022-04-07 | — | — | US | claimed |
| CN-108610290-B | Preparation method of fluxapyroxad | 武汉工程大学 | 2020-04-24 | — | — | CN | claimed |
| CN-110117256-A | A kind of synthetic method of biphenyl pyrrole bacterium amine | 苪城县斯普伦迪生物工程有限公司 | 2019-08-13 | — | — | CN | claimed |
| EP-2253623-A1 | New crystal form of a pyrazole fungicide | Syngenta Participations AG. (CH) | 2010-11-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509417-B2 | Enantioselective process | HCCS, AOC3, CYP8B1 | KLKB1 4787/4885CYP11B1 88/4885CYP11B2 100/4885 |
| US-20220106263-A1 | ENANTIOSELECTIVE PROCESS | CYP11B2, CYP2E1, CYP2F1 | KLKB1 4338/4885CYP11B1 6/4885CYP11B2 1/4885 |
| US-12491503-B2 | Hydrogenation process of oxime derivatives | HMOX2, HAO2, PRDX5 | KLKB1 4480/4885CYP11B1 119/4885CYP11B2 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.